Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 9,295 | 6,610 | 5,199 | 4,439 | 6,479 |
| Operating Income | -9,295 | -6,610 | -5,199 | -4,439 | -6,479 |
| Interest Expense | 0 | 0 | 658 | 0 | 0 |
| Other Income | 398 | 491 | -3 | 517 | 445 |
| Pre-tax Income | -8,897 | -6,119 | -5,860 | -3,922 | -6,034 |
| Net Income Continuous | -8,897 | -6,119 | -5,860 | -3,922 | -6,034 |
| Net Income | $-8,897 | $-6,119 | $-5,860 | $-3,922 | $-6,034 |
| EPS Basic Total Ops | -1.43 | -1.00 | -0.94 | -0.63 | -0.93 |
| EPS Basic Continuous Ops | -1.43 | -0.99 | -0.94 | -0.63 | -0.93 |
| EPS Diluted Total Ops | -1.43 | -1.00 | -0.94 | -0.63 | -0.93 |
| EPS Diluted Continuous Ops | -1.43 | -0.99 | -0.94 | -0.63 | -0.93 |
| EPS Diluted Before Non-Recurring Items | -1.43 | -0.99 | -0.94 | -0.63 | -0.90 |
| EBITDA(a) | $-9,295 | $-6,610 | $-5,202 | $-4,424 | $-6,447 |